Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Autonomix Medical, Inc.AMIX · Entity 8309 | CFO | September 03, 2026 | September 21, 2026 |
| InfuSystem Holdings, IncINFU · Entity 6163 | Exec VP,CAO & Corp Controller | September 07, 2017 | September 08, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Autonomix Medical, Inc.
Report date September 03, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,119 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 15,000 · Balance 15,119 F1: Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.
InfuSystem Holdings, Inc
Report date September 07, 2017 · Filed September 08, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.98 · Expires 2022-09-07 | Direct | 25,000 |
Reported balance
After 2017-09-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-09-07 · Grant · Acquired 25,000 · Balance 25,000 F1: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning September 7, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning September 7, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 21, 2026 12:13 UTC | Autonomix Medical, Inc. AMIX · Entity 8309 | GrantCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-030774 · rdgdoc.xml · nonDerivative · entry 1 Smith Trent N. · CIK 0001705689 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,119 F1 · price: Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC | Autonomix Medical, Inc. AMIX · Entity 8309 | Disposition to issuerOption (Right to buy) · Derivative | 21,250 | Not disclosed Strike: $40.00 | Not disclosed |
DisclosureSEC source: 0001437749-25-026636 · rdgdoc.xml · derivative · entry 2 Smith Trent N. · CIK 0001705689 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 21,250 shares Expires 2033-07-21 F1 · derivative.exercise_price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation. F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation. F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation. F2 · balance_after: Amount represents a revised share amount based on a 1-for-20 reverse stock split from October 25, 2024. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:08 UTC | Autonomix Medical, Inc. AMIX · Entity 8309 | Disposition to issuerOption (Right to buy) · Derivative | 11,405 | Not disclosed Strike: $26.56 | Not disclosed |
DisclosureSEC source: 0001437749-25-026636 · rdgdoc.xml · derivative · entry 1 Smith Trent N. · CIK 0001705689 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 11,405 shares Expires 2034-06-21 F1 · derivative.exercise_price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation. F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation. F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation. Read SEC document |
| June 21, 2024 Filed Jun 24, 2024 17:08 UTC | Autonomix Medical, Inc. AMIX · Entity 8309 | GrantOption (Right to buy) · Derivative | 228,087 | Not disclosed Strike: $1.33 | Not disclosed |
DisclosureSEC source: 0001437749-24-021104 · rdgdoc.xml · derivative · entry 1 Smith Trent N. · CIK 0001705689 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 678,087 Underlying: Common Stock · 228,087 shares Expires 2034-06-21 F2 · price: Issued in connection with the reporting person's employment with the Company F1 · derivative.exercise_date: The option set forth in this table vests in four annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 19:12 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001014108-17-000152 · primary_doc.xml · derivative · entry 1 Smith Trent N. · CIK 0001705689 · Exec VP,CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-09-07 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning September 7, 2018. Read SEC document |
| March 16, 2017 Filed May 4, 2017 19:23 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001014108-17-000096 · primary_doc.xml · derivative · entry 1 Smith Trent N. · CIK 0001705689 · Exec VP,CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-03-16 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 20,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning on April 16, 2017. Read SEC document |
| August 18, 2016 Filed May 4, 2017 19:17 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001014108-17-000095 · primary_doc.xml · derivative · entry 1 Smith Trent N. · CIK 0001705689 · Exec VP,CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2026-08-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning on September 18, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.